Europe Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The anatomic pathology market is projected to grow significantly, reaching approximately USD 14,999.93 million by 2031, up from USD 8,461.65 million in 2023. This growth represents a compound annual growth rate (CAGR) of 7.4% from 2023 to 2031.

Executive Summary and European Market Overview

In Europe, the anatomic pathology market is divided into several key countries, including Germany, France, the UK, Italy, Spain, and other regions. The growth of this market in Europe is primarily driven by the increasing incidence of cancers, particularly cervical and breast cancer. Additionally, various cancer screening initiatives implemented by health authorities aim to lower the prevalence of chronic diseases, which is expected to create further growth opportunities in the market.

Market Segmentation Analysis

The European anatomic pathology market can be analyzed through several segments: products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented based on applications into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in disease diagnosis and treatment.

Market Outlook

Anatomic pathology plays a crucial role in diagnosing various diseases, including autoimmune disorders, kidney and liver diseases, and cancers. Histopathology, which focuses on examining tissue changes due to diseases, is particularly vital in cancer diagnosis. Cancer remains a significant global health challenge, being one of the leading causes of death worldwide. The World Health Organization (WHO) identifies cancer as the second leading cause of mortality globally. In 2022, approximately 20 million new cancer cases were reported, and nearly 10 million deaths were attributed to cancer in 2020. In the UK alone, around 392,000 new cancer diagnoses occur annually, with approximately 167,000 deaths each year due to the disease.

The rising prevalence of chronic kidney disease, driven by an aging population, further emphasizes the importance of anatomic pathology techniques such as biopsies for detecting cancer and kidney diseases. As the incidence of cancer and other chronic diseases rises, healthcare providers, government agencies, and institutions are increasingly focused on enhancing disease diagnosis and treatment initiatives. This trend is expected to propel the growth of the anatomic pathology market in Europe.

Country-Specific Insights

The European anatomic pathology market includes key countries such as the UK, Germany, France, Italy, Spain, and others. Germany held the largest market share in 2023, largely due to the significant recognition of cytology, especially in relation to cervical cancer screening programs. The German government has been proactive in improving medical infrastructure, particularly through its cervical cancer screening program, which was updated in January 2020 to include co-testing for cytology and human papillomavirus (HPV) every three years for women aged 35 and older.

The increase in cervical cancer cases has led to a rise in screening initiatives across Germany. Recent studies indicate that cytology remains a critical component of cervical cancer screening, and the implementation of mass primary high-risk HPV screening may contribute to the eventual elimination of cervical cancer. The presence of esteemed research institutions in Germany also supports the advancement of innovative pathology tests aimed at early disease detection and prevention. For instance, the Institute for Pathology in Cologne processes around 40,000 surgical specimens and conducts 150 postmortems annually, underscoring the robust pathology services available in the country.

Company Profiles

Key players in the European anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

In conclusion, the European anatomic pathology market is poised for substantial growth, driven by the rising prevalence of cancer and chronic diseases, alongside ongoing advancements in medical technology and screening initiatives.

Product Code: TIPRE00026304

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.2.2 Stringent Government Regulations
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Europe Analysis

6.1 Europe Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Europe Anatomic Pathology Market Forecast Analysis

7. Europe Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Anatomic Pathology Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Anatomic Pathology Market Overview
- 10.1.2 Europe Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 United Kingdom: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Germany: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Germany: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Germany: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Germany: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Germany: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 France: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 France: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 France: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 France: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 France: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.4 Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Italy: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.4.1.1 Italy: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.4.1.2 Italy: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.4.2 Italy: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.4.3 Italy: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.5 Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 Spain: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.5.1.1 Spain: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.5.1.2 Spain: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.5.2 Spain: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.5.3 Spain: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.6 Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.6.1.1 Rest of Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.6.1.2 Rest of Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.6.2 Rest of Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.6.3 Rest of Europe Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Europe Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Diapath S.p.A.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bio SB
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PHC Holdings Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms